Your session is about to expire
← Back to Search
Exercise Training for Kidney Cancer
Study Summary
This trial is testing the effects of personalized exercises on quality of life and inflammation.
- Kidney Cancer
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have received radiation therapy for renal cell carcinoma within 28 days before starting the study.You have cancer that has spread to your spine, pelvis, or lower limbs.You are currently not very active or moderately active based on a specific questionnaire.You have a history of heart, lung, bone, or joint problems that make it difficult for you to do moderate physical activities.You have brain tumors that are not being controlled with medication or radiation.You are currently receiving a specific type of immunotherapy treatment or are about to start it within four weeks.You are able to do daily activities with little or no help, and are expected to live for at least six more months.Your bone marrow and organs are working well based on recent tests.You have been diagnosed with kidney cancer through a tissue biopsy.You have a type of cancer that has spread to other parts of the body and can be measured using specific guidelines.
- Group 1: Supportive Care
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this investigation include participants of advanced age?
"To be eligible for this medical trial, applicants must be between 18 and 99 years old. The database reveals 83 clinical trials specifically designed to accommodate people under the age of majority while 2564 are available to those aged over 65."
Are participants being accepted for this research endeavor at present?
"Affirmative, the clinicaltrials.gov website indicates that this medical study is still open for recruitment. It was initially posted on February 17th 2022 and last updated on March 28th 2022; 16 patients are required at one hospital site."
Could I be considered a participant in this research?
"This scientific experiment is recruiting sixteen individuals with carcinoma who are between eighteen and ninety-nine years of age. To be eligible for enrollment, people must meet a set of criteria including: having metastatic measurable disease, being treated by the standard Programmed cell death protein 1 (anti-PD-1) or anti-PD-L1 immune checkpoint inhibitor containing regimen, a histologically confirmed diagnosis of RCC, Eastern Cooperative Oncology Group performance status 0 to 2 and life expectancy exceeding six months, physical ability to participate in an exercise program evaluated by Physical medicine and rehabilitation physicians at Johns Hopkins University Hospital Medical Center; Absolute Neutroph"
How many participants are taking part in this research study?
"Affirmative. The clinicaltrial.gov website reports that this study is actively recruiting participants; it was initially published on February 17th 2022 and subsequently modified on March 28th 2022. Additionally, 16 individuals must be enrolled at one medical site for the trial to commence."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger